--- title: World-first Scalp Cooling Summit unites industry leaders to discuss future of supportive cancer care description: The first-of-its-kind Scalp Cooling Summit will take place digitally on May 5th, 2022, delivering keynote discussions and roundtables led by innovative world leaders in oncology and research and live Q&A sessions. image: https://news.lifesciencenewswire.com/hubfs/A%20patient%20undergoing%20scalp%20cooling%20treatment.jpg --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [World-first Scalp Cooling Summit unites industry leaders to discuss future of supportive cancer care](https://news.lifesciencenewswire.com/newsroom/world-first-scalp-cooling-summit-unites-industry-leaders-to-discuss-future-of-supportive-cancer-care) April 25, 2022 [![A patient undergoing scalp cooling treatment](https://news.lifesciencenewswire.com/hs-fs/hubfs/A%20patient%20undergoing%20scalp%20cooling%20treatment.jpg?width=422&name=A%20patient%20undergoing%20scalp%20cooling%20treatment.jpg)](https://drive.google.com/file/d/1W3KKI5s1sc6LW8ekdZ4kIb_luZOpyNJB/view?usp=sharing)The world’s first [Scalp Cooling Summit](https://scalpcoolingsummit.com/) will unite global oncology and research thought leaders to discuss current practice and how to advance the future of scalp cooling and side effect management in cancer care. Taking place digitally on May 5th, 2022, this first of its kind Summit will deliver keynote discussions and roundtables led by innovative world leaders in oncology and research and live Q&A sessions. The Summit’s aim is to provide a virtual space to inspire those working in oncology to see the importance and potential of scalp cooling in individual symptom management, and provide them the tools to implement better scalp cooling in their practice. The free-to-attend international event is open to all oncology healthcare professionals globally, and will provide attendees with the opportunity to collaborate with other delegates via open forums, networking halls, and drop-in sessions with the keynote speakers. The day will explore a range of topics including: - the impact of persistent chemotherapy-induced alopecia as a result of docetaxel - how scalp cooling can limit the psychosocial impact of hair loss on patients - the role of onco-dermatology in a patient’s treatment journey - the importance of equity in side effect management 46 speakers from a spectrum of disciplines and institutions, experts in their professional field and patient advocates will be joining the event virtually from all over the globe, to explore the future of supportive cancer care. Speakers include President Elect of the Multinational Association of Supportive Care in Cancer (MASCC) Dr Maryam Lustberg; Dr Mario Lacouture, Dr Julie Nangia, Maimah Karmo, founder of Tigerlily Foundation; Dr Stephanie Graff, Dr Amy Comander, Dr Charles Loprinzi and Dr Corina van den Hurk. Following the event the Summit will become a long-term educational platform where all content will be available to delegates on-demand, to allow them to revisit or explore in greater detail at a time convenient to them. It is being supported by The International Society of Nurses in Cancer Care, The UK Association of Supportive Care in Cancer and The Japanese Association of Supportive Care in Cancer. Richard Paxman, CEO of Paxman said: *“The Scalp Cooling Summit is a world-first event that aims to push the boundaries of side effect management in cancer care. We are delighted to be bringing together global pioneers to explore new ideas and embark in open and honest discussions on how to progress precision side effect management and advance scalp cooling. The event features a thought-provoking agenda and aims to provide an unrivalled platform for delegates to network with and learn from their peers, inspire conversation, and challenge perspectives.”* Scalp cooling is a pioneering technology designed to help maintain the quality of life for cancer patients facing chemo-induced hair loss. The novel treatment provides cancer patients with the only real alternative to this devastating side effect, which can often be an unwanted reminder of their disease and can compromise their self-image. The simple treatment involves patients wearing a ‘cold cap’ which works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy. This in turn reduces the blood flow carrying chemotherapy drugs to hair follicles, which can prevent or minimize hair loss. The virtual Scalp Cooling Summit will be taking place on May 5th, 2022 10:00am –6.15pm EST / 9:00am –5:00pm BST (Extended agenda 5:00pm – 11:15pm BST). To view the US/South America agenda and to register as a delegate for free, visit [www.scalpcoolingsummit.com](http://www.scalpcoolingsummit.com) To view the UK/Europe agenda and to register as a delegate for free, visit [www.scalpcoolingsummit.com](http://www.scalpcoolingsummit.com) More Information - [https://scalpcoolingsummit.com/](https://scalpcoolingsummit.com/) The world’s first Scalp Cooling Summit – where innovative global leaders in oncology and research will share their knowledge and understanding of precision side effect management, creating a platform where clinicians can learn, join conversations, and challenge themselves to advance the future of supportive cancer care and scalp cooling. The Scalp Cooling Summit aims to push the boundaries of side effect management in cancer care and we are looking for those who are pioneers and are open to exploring new ideas. The Summit is for the innovators, change makers, scalp cooling champions, and those on the ground delivering exceptional patient care. There are no requirements to be a Summit delegate, only an open mind and an interest in scalp cooling, precision side effect management and patient centric care in oncology. Essentially, the Summit is open to anyone in healthcare, and a great place to network with and learn from peers. Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)